Food-Pharma Convergence in Medical Nutrition– Best of Both Worlds?

At present, industries within the health and life science sector are moving towards one another resulting in new industries such as the medical nutrition industry. Medical nutrition products are specific nutritional compositions for intervention in disease progression and symptom alleviation. Industry convergence, described as the blurring of boundaries between industries, plays a crucial role in the shaping of new markets and industries. Assuming that the medical nutrition industry has emerged from the convergence between the food and pharma industries, it is crucial to research how and which distinct industry domains have contributed to establish this relatively new industry. The first two stages of industry convergence (knowledge diffusion and consolidation) are measured by means of patent analysis. First, the extent of knowledge diffusion within the medical nutrition industry is graphed in a patent citation interrelations network. Subsequently the consolidation based on technological convergence is determined by means of patent co-classification. Furthermore, the medical nutrition core domain and technology interrelations are measured by means of a cross impact analysis. This study proves that the medical nutrition industry is a result of food and pharma convergence. It is therefore crucial for medical nutrition companies to effectively monitor technological developments within as well as across industry boundaries. This study further reveals that although the medical nutrition industry’s core technology domain is food, technological development is mainly driven by pharmaceutical/pharmacological technologies Additionally, the results indicate that the industry has surpassed the knowledge diffusion stage of convergence, and is currently in the consolidation phase of industry convergence. Nevertheless, while the medical nutrition can be classified as an industry in an advanced phase of convergence, one cannot predict that the pharma and food industry segments will completely converge or whether the medical industry will become an individual successful industry.

[1]  Kuei-Kuei Lai,et al.  Exploring technology diffusion and classification of business methods: Using the patent citation network , 2009 .

[2]  J. Leker,et al.  Patent indicators for monitoring convergence - examples from NFF and ICT , 2011 .

[3]  Fang-Mei Tseng,et al.  Using patent data to analyze trends and the technological strategies of the amorphous silicon thin-film solar cell industry , 2011 .

[4]  S. E. Sohaimy,et al.  Functional Foods and Nutraceuticals-Modern Approach to Food Science , 2012 .

[5]  I. Vertinsky,et al.  Cross impact analysis of technological innovation and development in the softwood lumber industry in Canada: a structural modeling approach , 1991 .

[6]  István Siró,et al.  Functional food. Product development, marketing and consumer acceptance—A review , 2008, Appetite.

[7]  D R Farr,et al.  Functional foods. , 1997, Cancer letters.

[8]  Sungjoo Lee,et al.  Technological Convergence of IT and BT: Evidence from Patent Analysis , 2012 .

[9]  S. Bell,et al.  Prescription for Nutritional Healing , 1990 .

[10]  Harry Commandeur,et al.  Barriers to innovation in the medical nutrition industry: A quantitative key opinion leader analysis , 2013 .

[11]  L. Gilbert.  The Consumer Market for Functional Foods , 1998 .

[12]  P. Fürst,et al.  Amino-acid substrates in new bottles: implications for clinical nutrition in the 21st century. , 2000, Nutrition.

[13]  Bruno Van Pottelsberghe,et al.  Using patent counts for cross-country comparisons of technology output , 2001 .

[14]  David B. Yoffie,et al.  Competing in the Age of Digital Convergence , 1997 .

[15]  Lada A. Adamic,et al.  The Impact of Boundary Spanning Scholarly Publications and Patents , 2009, PloS one.

[16]  Patent Manuel,et al.  USING PATENT DATA AS SCIENCE AND TECHNOLOGY INDICATORS , 1994 .

[17]  H. Commandeur,et al.  Risk in Vaccine Research and Development Quantified , 2013, PloS one.

[18]  R. Witkamp,et al.  Pharma-nutrition interface: the gap is narrowing. , 2011, European journal of pharmacology.

[19]  Bart Bossink,et al.  Managing drivers of innovation in construction networks , 2004 .

[20]  M. Trajtenberg.  A Penny for Your Quotes : Patent Citations and the Value of Innovations , 1990 .

[21]  Fredrik Hacklin,et al.  Management of Convergence in Innovation: Strategies and Capabilities for Value Creation Beyond Blurring Industry Boundaries , 2007 .

[22]  Holger Ernst,et al.  The Use of Patent Data for Technological Forecasting: The Diffusion of CNC-Technology in the Machine Tool Industry , 1997 .

[23]  Selwyn Enzer,et al.  Cross-impact techniques in technology assessment , 1972 .

[24]  F. Kodama,et al.  Technological diversity of persistent innovators in Japan: Two case studies of large Japanese firms , 2004 .

[25]  A. Valle,et al.  Diffusion of nuclear energy in some developing countries , 2014 .

[26]  S. V. Delft.  Inter-industry innovations in terms of electric mobility: should firmstake a look outside their industry? , 2013 .

[27]  Soung Hie Kim,et al.  A qualitative cross-impact approach to find the key technology , 1997 .

[28]  Jan Tobochnik,et al.  Modeling innovation by a kinetic description of the patent citation system , 2005 .

[29]  Hakyeon Lee,et al.  Identifying core technologies based on technological cross-impacts: An association rule mining (ARM) and analytic network process (ANP) approach , 2011, Expert Syst. Appl..

[30]  Hakyeon Lee,et al.  An ANP-based technology network for identification of core technologies: A case of telecommunication technologies , 2009, Expert Syst. Appl..

[31]  F. Malerba,et al.  Knowledge-relatedness in firm technological diversification , 2003 .

[32]  J. Leker,et al.  The Front End of Innovation in an Era of Industry Convergence: Evidence from Nutraceuticals and Functional Foods , 2006 .

[33]  Michael Blackman,et al.  Provision of patent information: a national patent office perspective , 1995 .

[34]  J. Leker,et al.  Anticipating converging industries using publicly available data , 2010 .

[35]  J. Howlett.  Functional foods: from science to health and claims. , 2008 .

[36]  Harry Commandeur,et al.  Patenting in the European medical nutrition industry: Trends, opportunities and strategies , 2013 .

[37]  Dirk Thorleuchter,et al.  A compared R&D-based and patent-based cross impact analysis for identifying relationships between technologies , 2010 .

[38]  Klaus G. Grunert,et al.  Three issues in consumer quality perception and acceptance of dairy products , 2000 .

[39]  Jens Leker,et al.  Industry Convergence and its Implications for the Front End of Innovation: A Problem of Absorptive Capacity , 2007 .

[40]  Hans Verhagen,et al.  Functional foods and dietary supplements: products at the interface between pharma and nutrition. , 2011, European journal of pharmacology.

[41]  Byungun Yoon,et al.  A text-mining-based patent network: Analytical tool for high-technology trend , 2004 .

[42]  Benjamin Weaver.  Research proposal: Industry convergence - Driving forces, factors and consequences , 2007 .

[43]  C. Prahalad.  Managing discontinuities : The emerging challenges , 1998 .

[44]  Kristina Dahlin,et al.  When is an Invention Really Radical? Defining and Measuring Technological Radicalness , 2005 .

[45]  Yongtae Park,et al.  A patent-based cross impact analysis for quantitative estimation of technological impact: The case of information and communication technology , 2007 .

[46]  Michael L. Katz,et al.  Remarks on the Economic Implications of Convergence , 1996 .

[47]  Ratapol P. Teratanavat,et al.  Consumer Valuations and Preference Heterogeneity for a Novel Functional Food , 2006 .

[48]  M. Trajtenberg,et al.  International Knowledge Flows: Evidence from Patent Citations , 1998 .

[49]  Hans Verhagen,et al.  Status of nutrition and health claims in Europe. , 2010, Archives of biochemistry and biophysics.

[50]  Sir,et al.  Our food, our health - Healthy diet and safe food in the Netherlands , 2006 .

[51]  D. Popp,et al.  Renewable Energy Policies and Technological Innovation: Evidence Based on Patent Counts , 2008 .

[52]  Tuomo Kässi,et al.  Patent citations as a tool for analysing the early stages of convergence , 2013 .

[53]  H. Commandeur,et al.  Bridging a pharma-like innovation gap in medical nutrition , 2014 .

[54]  Gregory F. Nemet,et al.  Do Important Inventions Benefit from Knowledge Originating in Other Technological Domains? , 2011 .

[55]  J. Weststrate,et al.  Functional foods, trends and future. , 2002, The British journal of nutrition.

[56]  Joseph Plasmans,et al.  Measuring Knowledge Spillovers Using Patent Citations: Evidence from the Belgian Firm's Data , 2002 .

[57]  Geert Duysters,et al.  Technological Convergence in the IT Industry: The Role of Strategic Technology Alliances and Technological Competencies , 1998 .